Another clinical trial found that elevated GH levels significantly improved nitrogen retention , a key factor in muscle growth
Phase 3 trials under the TRIUMPH program are ongoing, testing retatrutide in obesity, type 2 diabetes, sleep apnea, knee osteoarthritis, and chronic kidney disease
The same goes for individuals suffering from certain genetic issues
Wegovy (semaglutide) is an injectable medication used for weight loss in adults with obesity or overweight who also have at least one weight-related health condition
Semaglutide is a GLP-1 receptor agonist that primarily acts on receptors in the brain (appetite regulation), pancreas (insulin secretion), and gastrointestinal tract (gastric emptying)
Researchers might investigate its role in mitigating fatty liver conditions or improving overall liver metabolic markers